Structure/Function Claim Nutritive Value Debate Reopened By FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA is seeking feedback on both its current regulatory approach to dietary supplement products bearing nutritive value-based structure/function claims and the potential impact of a policy reversal on the issue.
You may also be interested in...
OTC Drug Review’s Constitutionality Questioned By CHPA
FDA's OTC Drug Review could be challenged on constitutional grounds, the Consumer Healthcare Products Association states in Sept. 13 comments to the agency
OTC Drug Review’s Constitutionality Questioned By CHPA
FDA's OTC Drug Review could be challenged on constitutional grounds, the Consumer Healthcare Products Association states in Sept. 13 comments to the agency
OTC Drug Review’s Constitutionality Questioned By CHPA
FDA's OTC Drug Review could be challenged on constitutional grounds, the Consumer Healthcare Products Association states in Sept. 13 comments to the agency